4Li Q, Zemel E, Miller B, et al.Early retinal damage in experi- mental diabetes: eleetroretinographieal and morphological observa- tios[J].Exp Eye Res.2002,74:615-625.
6Kowluru RA, Zhong Q. Beyond AREDS:is there a place for antioxidant therapy in the prevention/treatment of the eye disease. Invest Ophthalmol Vis Sci, 2011, 52(12):8665-8671.
7Xie XW, Xu L, Wang YX, et al. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol, 2008, 246(11): 1519-1526.
8Okamoto F, Okamoto Y, Fukuda S, et al. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy. Ophthalmology, 2008, 145(6):1031-1036.
9Bhavsar AR, Googe JM Jr, Stockdale CR, et al. Risk of endophthal- mitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser- ranibizumab-triamcinolone clinical trials. Arch Ophthalmol, 2009, 127(12): 1581-1583.
